AMH Equity Ltd. recently announced the acquisition of new stake in Foresight Autonomous Holdings Ltd ADR (NASDAQ:FRSX). This fresh investment now brings its stake to 0.28% valued currently at $44269.0. In addition, Morgan Stanley & Co. LLC raised its holdings by 2125.0 to 27414.0 shares.
Currently, there are 15.33M common shares owned by the public and among those 10.83M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The top 3 mutual fund holders in Foresight Autonomous Holdings Ltd ADR are Migdal, Fidelity Nasdaq Composite Index F, and Torrecares Inversiones SICAV. Migdal owns 750.0 shares of the company’s stock, all valued at over $773.0. Torrecares Inversiones SICAV sold 1685.0 shares to bring its total holdings to over 0.0 shares at a value of $0.0. Torrecares Inversiones SICAV now owns shares totaling to 0.00% of the shares outstanding.
The company’s stock has a 5-day price change of 51.68% and -16.67% over the past three months. FRSX shares are trading 35.92% year to date (YTD), with the 12-month market performance down to -58.49% lower. It has a 12-month low price of $0.90 and touched a high of $4.58 over the same period. FRSX has an average intraday trading volume of 119.32K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 35.65%, 5.69%, and -30.43% respectively.
Institutional ownership of Foresight Autonomous Holdings Ltd ADR (NASDAQ: FRSX) shares accounts for 0.81% of the company’s 15.33M shares outstanding. Mutual fund holders own 0.01%, while other institutional holders and individual stakeholders account for 0.81% and — respectively.
It has a market capitalization of $21.46M and a beta (3y monthly) value of 2.14. The earnings-per-share (ttm) stands at -$1.73. Price movements for the stock have been influenced by the stock’s volatility, which stands at 18.07% over the week and 10.46% over the month.
The lowest estimate earnings-per-share for the quarter is $0 while analysts give the company a high EPS estimate of $0.
Looking at the support for the FRSX, a number of firms have released research notes about the stock. The Benchmark Company stated their Speculative Buy rating for the stock in a research note on March 02, 2018, with the firm’s price target at $16.
